Top

Published in:

01-03-2015

Echocardiography in cardiac amyloidosis

Authors: Rodney H. Falk, C. Cristina Quarta

Published in: Heart Failure Reviews | Issue 2/2015

Abstract

Echocardiography is the most widely used noninvasive test in patients with heart failure or abnormal cardiac findings on examination. Patients with amyloidosis may have significant cardiac abnormalities, several of which are highly suggestive of the disease. This article reviews echocardiographic features found in cardiac amyloidosis.

Carroll JD, Gaasch WH, McAdam KP (1982) Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation. Am J Cardiol 49:9–13CrossRefPubMed

Klein AL, Hatle LK, Taliercio CP et al (1991) Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study. Circulation 83:808–816CrossRefPubMed

Cueto-Garcia L, Reeder GS, Kyle RA et al (1985) Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 6:737–743CrossRefPubMed

Patel AR, Dubrey SW, Mendes LA et al (1997) Right ventricular dilation in primary amyloidosis: an independent predictor of survival. Am J Cardiol 80:486–492CrossRefPubMed

Cappelli F, Porciani MC, Bergesio F et al (2012) Right ventricular function in AL amyloidosis: characteristics and prognostic implication. Eur Heart J Cardiovasc Imaging 13:416–422CrossRefPubMed

Dubrey SW, Cha K, Skinner M, LaValley M, Falk RH (1997) Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart 78:74–82CrossRefPubMedCentralPubMed

Koyama J, Falk RH (2010) Prognostic significance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging 3:333–342CrossRefPubMed

Quarta CC, Solomon SD, Uraizee I et al (2014) Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. Circulation 129:1840–1849CrossRefPubMed

Phelan D, Collier P, Thavendiranathan P et al (2012) Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 98:1442–1448CrossRefPubMed

10.

Modesto KM, Dispenzieri A, Cauduro SA et al (2005) Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques. Eur Heart J 26:173–179CrossRefPubMed

11.

Dubrey S, Pollak A, Skinner M, Falk RH (1995) Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation [see comments]. Br Heart J 74:541–544CrossRefPubMedCentralPubMed

12.

Feng D, Edwards WD, Oh JK et al (2007) Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation 116:2420–2426CrossRefPubMed

13.

Feng D, Syed IS, Martinez M et al (2009) Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis. Circulation 119:2490–2497CrossRefPubMed

14.

Ogawa H, Mizuno Y, Ohkawara S et al (2001) Cardiac amyloidosis presenting as microvascular angina—a case report. Angiology 52:273–278CrossRefPubMed

15.

Tsai SB, Seldin DC, Wu H, O’Hara C, Ruberg FL, Sanchorawala V (2011) Myocardial infarction with “clean coronaries” caused by amyloid light-chain AL amyloidosis: a case report and literature review. Amyloid 18:160–164CrossRefPubMed

16.

Dinwoodey DL, Skinner M, Maron MS, Davidoff R, Ruberg FL (2008) Light-chain amyloidosis with echocardiographic features of hypertrophic cardiomyopathy. Am J Cardiol 101:674–676CrossRefPubMed

17.

Philippakis AA, Falk RH (2012) Cardiac amyloidosis mimicking hypertrophic cardiomyopathy with obstruction: treatment with disopyramide. Circulation 125:1821–1824CrossRefPubMed

18.

Allen RD, Edwards WD, Tazelaar HD, Danielson GK (2003) Surgical pathology of subaortic septal myectomy not associated with hypertrophic cardiomyopathy: a study of 98 cases (1996–2000). Cardiovasc Pathol 12:207–215CrossRefPubMed

19.

Bockorny M, Chakravarty S, Schulman P, Bockorny B, Bona R (2012) Severe heart failure after bortezomib treatment in a patient with multiple myeloma: a case report and review of the literature. Acta Haematol 128:244–247CrossRefPubMed

Title: Echocardiography in cardiac amyloidosis
Authors: Rodney H. Falk
C. Cristina Quarta
Publication date: 01-03-2015
Publisher: Springer US
Published in: Heart Failure Reviews / Issue 2/2015
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-014-9466-3

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Echocardiography in cardiac amyloidosis

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2015

Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs

Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis

Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart

Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment

Natural history and therapy of AL cardiac amyloidosis

Nuclear imaging for cardiac amyloidosis

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page